Abbott MediaRoom - Press Releases

Month Year

Oct 28, 2022
- Photos 1
Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation
Oct 19, 2022
- Photos 1
Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance
Jul 20, 2022

Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
Jun 8, 2022

Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices

- New results demonstrate MitraClip™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR)
- Data from the first report on patients with a pacemaker lead across the tricuspid valve show TriClip™ and TriClip G4 TEER systems significantly reduce tricuspid regurgitation (TR) and substantially improve quality of life
May 24, 2022
- Photos 1
Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need
May 16, 2022
- Photos 1
Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility
Apr 29, 2022
- Photos 1
Abbott to Release Metabolic Nutrition Formulas
Apr 20, 2022
- Photos 1
Abbott Reports First-Quarter 2022 Results
Mar 1, 2022

Military Members, Families and Retirees Get Simplified Access to Abbott’s FreeStyle® Libre 2 system Through TRICARE®

- TRICARE members now have faster, easier, and more convenient access to continuous glucose monitoring
- Abbott’s FreeStyle Libre 2 system will now be on the brand-name formulary and available through retail pharmacies, home delivery and military treatment facilities
Feb 3, 2022

UnitedHealthcare Extends Coverage to Abbott’s Unique Neurostimulation Therapy for Nerve Pain

- Abbott’s Proclaim™ dorsal root ganglion (DRG) neurostimulation system is the only FDA-approved DRG technology for the treatment of CRPS I and causalgia of the lower extremitiesⁱ
- UnitedHealthcare is the largest private health insurance company in the U.S, providing coverage for more than 44 million healthcare membersⁱⁱ

Show per page

true

accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

yes no

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?

yes no

accessibility

Asset Warning

yes no

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

PRESS RELEASES

You are about to exit for another Abbott country or region specific website

Do you wish to continue and exit this website?

You are about to exit the Abbott family of websites for a 3rd party website

Do you wish to continue and exit this website?